Symbols / CJMB $1.33 +7.26% Callan JMB Inc.
CJMB Chart
About
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; perishable (non-pharma) client packaging; technical services; and advanced monitoring sentry technology. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
Fundamentals
Scroll to Statements| Sector | Industrials | Industry | Integrated Freight & Log | Market Cap | 5.96M |
| Enterprise Value | 7.34M | Income | -7.97M | Sales | 5.72M |
| Book/sh | 0.90 | Cash/sh | 0.38 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 1.04 | P/B | 1.47 | P/C | — |
| EV/EBITDA | -1.16 | EV/Sales | 1.28 | Quick Ratio | 1.75 |
| Current Ratio | 2.16 | Debt/Eq | 85.36 | LT Debt/Eq | — |
| EPS (ttm) | -1.82 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -14.10% | Earnings | — | ROA | -74.74% |
| ROE | -289.61% | ROIC | — | Gross Margin | 36.77% |
| Oper. Margin | -169.61% | Profit Margin | -139.20% | Shs Outstand | 4.48M |
| Shs Float | 1.72M | Short Float | 3.99% | Short Ratio | 0.52 |
| Short Interest | — | 52W High | 5.88 | 52W Low | 1.08 |
| Beta | — | Avg Volume | 3.73M | Volume | 45.08K |
| Target Price | — | Recom | None | Prev Close | $1.24 |
| Price | $1.33 | Change | 7.26% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- $CJMB stock is up 13% today. Here's what we see in our data. - Quiver Quantitative Mon, 16 Mar 2026 19
- Long COVID drug lodonal moves into trial as 20M Americans endure symptoms - Stock Titan Wed, 11 Mar 2026 07
- Callan JMB Insiders Lose Out As Stock Sinks To US$3.44 - simplywall.st Fri, 14 Nov 2025 08
- CJMB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI Wed, 01 Apr 2026 16
- Callan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility - finance.yahoo.com Mon, 12 Jan 2026 08
- A Tidal Wave of Challenges: Callan JMB’s Stock Plummets Amidst Unsettled Waters - timothysykes.com hu, 15 Jan 2026 08
- Croyle David J, chief medical officer, buys $17841 in Callan JMB Inc. - Investing.com hu, 26 Mar 2026 07
- CJMB Surges on Partnership News, But Volume Remains Skeptical - bitget.com Mon, 30 Mar 2026 05
- Callan JMB Stock (CJMB) Rockets 260% on Attune Biotech Deal - TipRanks hu, 15 Jan 2026 08
- Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update - The Globe and Mail ue, 31 Mar 2026 20
- Insider Purchase: Chief Medical Officer of $CJMB Buys 10,195 Shares - Quiver Quantitative hu, 26 Mar 2026 22
- 12 Industrials Stocks Moving In Tuesday's After-Market Session - benzinga.com ue, 24 Mar 2026 21
- Croyle David J, chief medical officer, buys Callan JMB (CJMB) shares - Investing.com ue, 10 Mar 2026 07
- $CJMB stock is up 127% today. Here's what we see in our data. - Quiver Quantitative hu, 15 Jan 2026 08
- Callan JMB Inc. (CJMB) Stock Price, News, Quote & History - ca.finance.yahoo.com Fri, 29 Aug 2025 06
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
5.72
-12.80%
|
6.56
-50.29%
|
13.20
-42.01%
|
22.77
|
| Operating Revenue |
|
5.72
-12.80%
|
6.56
-50.29%
|
13.20
-42.01%
|
22.77
|
| Cost Of Revenue |
|
3.62
-9.54%
|
4.00
-47.04%
|
7.55
-43.27%
|
13.32
|
| Reconciled Cost Of Revenue |
|
3.62
-9.54%
|
4.00
-47.04%
|
7.55
-43.27%
|
13.32
|
| Gross Profit |
|
2.10
-17.90%
|
2.56
-54.63%
|
5.65
-40.23%
|
9.45
|
| Operating Expense |
|
8.60
+77.70%
|
4.84
+40.35%
|
3.45
+9.29%
|
3.15
|
| Selling General And Administration |
|
8.60
+77.70%
|
4.84
+40.35%
|
3.45
+9.29%
|
3.15
|
| Total Expenses |
|
12.22
+38.21%
|
8.84
-19.66%
|
11.00
-33.21%
|
16.47
|
| Operating Income |
|
-6.49
-185.41%
|
-2.27
-203.30%
|
2.20
-65.03%
|
6.30
|
| Total Operating Income As Reported |
|
-7.03
-209.24%
|
-2.27
-203.30%
|
2.20
-65.03%
|
6.30
|
| EBITDA |
|
-7.81
-268.75%
|
-2.12
-191.54%
|
2.32
-63.66%
|
6.37
|
| Normalized EBITDA |
|
-6.90
-225.66%
|
-2.12
-191.54%
|
2.32
-63.66%
|
6.37
|
| Reconciled Depreciation |
|
0.15
+5.75%
|
0.14
+39.78%
|
0.10
+50.10%
|
0.07
|
| EBIT |
|
-7.97
-252.05%
|
-2.26
-202.29%
|
2.21
-64.90%
|
6.30
|
| Total Unusual Items |
|
-0.91
|
0.00
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.91
|
0.00
|
—
|
—
|
| Special Income Charges |
|
-0.54
|
0.00
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.54
|
0.00
|
—
|
—
|
| Net Income |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Pretax Income |
|
-7.97
-251.34%
|
-2.27
-202.91%
|
2.20
-64.99%
|
6.30
|
| Net Non Operating Interest Income Expense |
|
0.01
-7.90%
|
0.01
+219.41%
|
0.00
+133.43%
|
-0.01
|
| Interest Expense Non Operating |
|
0.00
-50.20%
|
0.01
-33.93%
|
0.01
+32.90%
|
0.01
|
| Net Interest Income |
|
0.01
-7.90%
|
0.01
+219.41%
|
0.00
+133.43%
|
-0.01
|
| Interest Expense |
|
0.00
-50.20%
|
0.01
-33.93%
|
0.01
+32.90%
|
0.01
|
| Interest Income Non Operating |
|
0.01
-26.99%
|
0.01
+16.98%
|
0.01
|
0.00
|
| Interest Income |
|
0.01
-26.99%
|
0.01
+16.98%
|
0.01
|
0.00
|
| Other Income Expense |
|
-1.48
|
—
|
—
|
0.00
|
| Other Non Operating Income Expenses |
|
-0.57
|
—
|
—
|
0.00
|
| Gain On Sale Of Security |
|
-0.37
|
—
|
—
|
—
|
| Tax Provision |
|
-0.00
-111.69%
|
0.03
+10.29%
|
0.02
-69.33%
|
0.07
|
| Tax Rate For Calcs |
|
0.00
-99.82%
|
0.00
+2000.00%
|
0.00
-9.09%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Net Income From Continuing Operation Net Minority Interest |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Net Income From Continuing And Discontinued Operation |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Net Income Continuous Operations |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Normalized Income |
|
-7.05
-207.52%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Net Income Common Stockholders |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Diluted EPS |
|
—
|
-0.54
-254.30%
|
0.35
-76.11%
|
1.45
|
| Basic EPS |
|
—
|
-0.54
-205.16%
|
0.51
-64.94%
|
1.45
|
| Basic Average Shares |
|
—
|
4.28
+0.00%
|
4.28
+0.00%
|
4.28
|
| Diluted Average Shares |
|
—
|
4.28
-31.85%
|
6.28
+46.73%
|
4.28
|
| Diluted NI Availto Com Stockholders |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
5.78
+13.64%
|
5.08
-47.63%
|
9.71
-36.36%
|
15.25
|
| Current Assets |
|
3.06
-7.85%
|
3.32
-60.73%
|
8.45
-41.18%
|
14.37
|
| Cash Cash Equivalents And Short Term Investments |
|
2.13
+1.56%
|
2.10
-59.31%
|
5.16
-16.76%
|
6.19
|
| Cash And Cash Equivalents |
|
2.13
+1.56%
|
2.10
-59.31%
|
5.16
-16.76%
|
6.19
|
| Cash Financial |
|
—
|
2.10
-59.31%
|
5.16
-16.76%
|
6.19
|
| Receivables |
|
0.34
-47.03%
|
0.65
-77.82%
|
2.92
-62.87%
|
7.87
|
| Accounts Receivable |
|
0.34
-44.90%
|
0.62
-78.51%
|
2.90
-63.07%
|
7.85
|
| Gross Accounts Receivable |
|
0.40
-41.05%
|
0.69
-79.04%
|
3.28
-58.78%
|
7.95
|
| Allowance For Doubtful Accounts Receivable |
|
-0.06
+3.63%
|
-0.06
+83.10%
|
-0.38
-272.38%
|
-0.10
|
| Taxes Receivable |
|
0.00
-100.00%
|
0.01
|
0.00
|
—
|
| Loans Receivable |
|
0.00
-100.00%
|
0.02
-15.02%
|
0.02
+32.09%
|
0.02
|
| Inventory |
|
0.24
+53.63%
|
0.16
+38.02%
|
0.11
+44.43%
|
0.08
|
| Raw Materials |
|
—
|
—
|
0.11
+44.43%
|
0.08
|
| Current Deferred Assets |
|
0.00
-100.00%
|
0.14
+444.10%
|
0.03
|
0.00
|
| Other Current Assets |
|
0.34
+22.38%
|
0.28
+18.18%
|
0.24
+2.81%
|
0.23
|
| Total Non Current Assets |
|
2.72
+54.09%
|
1.76
+40.72%
|
1.25
+42.15%
|
0.88
|
| Net PPE |
|
2.72
+54.41%
|
1.76
+40.84%
|
1.25
+42.33%
|
0.88
|
| Gross PPE |
|
4.02
+69.73%
|
2.37
+38.05%
|
1.72
+38.35%
|
1.24
|
| Accumulated Depreciation |
|
-1.30
-114.02%
|
-0.61
-30.56%
|
-0.47
-28.72%
|
-0.36
|
| Machinery Furniture Equipment |
|
2.00
+44.59%
|
1.38
+3.36%
|
1.34
+41.01%
|
0.95
|
| Other Properties |
|
2.02
+105.03%
|
0.99
+161.13%
|
0.38
+29.68%
|
0.29
|
| Non Current Prepaid Assets |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Total Liabilities Net Minority Interest |
|
3.45
+80.58%
|
1.91
+109.74%
|
0.91
-26.56%
|
1.24
|
| Current Liabilities |
|
1.41
+10.90%
|
1.27
+65.56%
|
0.77
-30.67%
|
1.11
|
| Payables And Accrued Expenses |
|
1.07
+32.00%
|
0.81
+68.57%
|
0.48
-37.88%
|
0.78
|
| Payables |
|
0.59
+48.76%
|
0.39
-18.30%
|
0.48
-37.88%
|
0.78
|
| Accounts Payable |
|
0.56
+51.75%
|
0.37
-10.68%
|
0.42
-37.68%
|
0.67
|
| Current Accrued Expenses |
|
0.49
+16.24%
|
0.42
|
—
|
—
|
| Total Tax Payable |
|
0.02
+0.37%
|
0.02
-65.67%
|
0.07
-39.09%
|
0.11
|
| Income Tax Payable |
|
0.02
+0.37%
|
0.02
-65.67%
|
0.07
-39.09%
|
0.11
|
| Current Debt And Capital Lease Obligation |
|
0.34
-7.54%
|
0.37
+36.77%
|
0.27
-5.01%
|
0.28
|
| Current Debt |
|
0.01
-83.45%
|
0.09
-25.18%
|
0.12
+5.07%
|
0.11
|
| Other Current Borrowings |
|
—
|
—
|
0.02
|
—
|
| Current Capital Lease Obligation |
|
0.32
+16.03%
|
0.28
+84.12%
|
0.15
-11.50%
|
0.17
|
| Current Deferred Liabilities |
|
0.00
-100.00%
|
0.09
+392.32%
|
0.02
-62.52%
|
0.05
|
| Current Deferred Revenue |
|
0.00
-100.00%
|
0.09
+676.83%
|
0.01
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
2.03
+220.45%
|
0.63
+351.67%
|
0.14
+8.75%
|
0.13
|
| Long Term Debt And Capital Lease Obligation |
|
1.66
+164.73%
|
0.63
+374.21%
|
0.13
+2.50%
|
0.13
|
| Long Term Capital Lease Obligation |
|
1.66
+164.73%
|
0.63
+374.21%
|
0.13
+2.50%
|
0.13
|
| Non Current Deferred Liabilities |
|
0.00
-100.00%
|
0.01
-18.24%
|
0.01
|
—
|
| Non Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
0.01
|
—
|
| Non Current Deferred Taxes Liabilities |
|
0.00
-100.00%
|
0.01
|
—
|
—
|
| Stockholders Equity |
|
2.33
-26.64%
|
3.17
-63.92%
|
8.80
|
0.00
|
| Common Stock Equity |
|
2.33
-26.64%
|
3.17
-63.92%
|
8.80
-37.23%
|
14.01
|
| Capital Stock |
|
0.00
+62.00%
|
0.00
|
0.00
|
—
|
| Common Stock |
|
0.00
+62.00%
|
0.00
|
0.00
|
—
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
—
|
| Share Issued |
|
4.62
+8.01%
|
4.28
+0.00%
|
4.28
+0.00%
|
4.28
|
| Ordinary Shares Number |
|
4.62
+8.01%
|
4.28
+0.00%
|
4.28
+0.00%
|
4.28
|
| Additional Paid In Capital |
|
12.58
+130.29%
|
5.46
|
0.00
|
—
|
| Retained Earnings |
|
-10.26
-347.32%
|
-2.29
|
0.00
|
—
|
| Total Equity Gross Minority Interest |
|
2.33
-26.64%
|
3.17
-63.92%
|
8.80
-37.23%
|
14.01
|
| Total Capitalization |
|
2.33
-26.64%
|
3.17
-63.92%
|
8.80
-37.23%
|
14.01
|
| Working Capital |
|
1.65
-19.54%
|
2.04
-73.38%
|
7.68
-42.06%
|
13.26
|
| Invested Capital |
|
2.34
-28.15%
|
3.26
-63.42%
|
8.91
-36.90%
|
14.12
|
| Total Debt |
|
2.00
+101.33%
|
0.99
+148.54%
|
0.40
-2.65%
|
0.41
|
| Capital Lease Obligations |
|
1.99
+118.98%
|
0.91
+219.40%
|
0.28
-5.48%
|
0.30
|
| Net Tangible Assets |
|
2.33
-26.64%
|
3.17
-63.92%
|
8.80
|
0.00
|
| Tangible Book Value |
|
2.33
-26.64%
|
3.17
-63.92%
|
8.80
-37.23%
|
14.01
|
| Current Deferred Taxes Liabilities |
|
—
|
0.01
-5.69%
|
0.01
-86.27%
|
0.05
|
| Current Notes Payable |
|
—
|
0.00
-100.00%
|
0.10
-10.41%
|
0.11
|
| Derivative Product Liabilities |
|
0.37
|
0.00
|
—
|
—
|
| Limited Partnership Capital |
|
—
|
—
|
8.80
-37.23%
|
14.01
|
| Line Of Credit |
|
0.01
-83.45%
|
0.09
|
—
|
—
|
| Other Equity Interest |
|
—
|
—
|
8.80
|
—
|
| Total Partnership Capital |
|
—
|
—
|
8.80
-37.23%
|
14.01
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.55
-941.44%
|
0.54
-92.28%
|
7.00
-25.29%
|
9.36
|
| Cash Flow From Continuing Operating Activities |
|
-4.55
-941.44%
|
0.54
-92.28%
|
7.00
-25.29%
|
9.36
|
| Net Income From Continuing Operations |
|
-7.97
-247.32%
|
-2.29
-205.16%
|
2.18
-64.94%
|
6.22
|
| Depreciation Amortization Depletion |
|
0.15
+5.75%
|
0.14
+39.78%
|
0.10
+50.10%
|
0.07
|
| Depreciation |
|
—
|
0.14
+39.78%
|
0.10
+50.10%
|
0.07
|
| Depreciation And Amortization |
|
0.15
+5.75%
|
0.14
+39.78%
|
0.10
+50.10%
|
0.07
|
| Other Non Cash Items |
|
0.52
|
—
|
—
|
—
|
| Stock Based Compensation |
|
1.56
|
0.00
|
—
|
—
|
| Provisionand Write Offof Assets |
|
0.23
+275.72%
|
-0.13
-147.29%
|
0.28
+172.38%
|
0.10
|
| Asset Impairment Charge |
|
0.54
|
0.00
|
—
|
—
|
| Operating Gains Losses |
|
0.37
|
—
|
—
|
—
|
| Gain Loss On Investment Securities |
|
0.37
|
—
|
—
|
—
|
| Change In Working Capital |
|
0.04
-98.41%
|
2.82
-36.38%
|
4.43
+49.20%
|
2.97
|
| Change In Receivables |
|
0.06
-97.67%
|
2.40
-48.63%
|
4.67
-32.09%
|
6.88
|
| Changes In Account Receivables |
|
0.05
-97.94%
|
2.41
-48.49%
|
4.67
-32.09%
|
6.88
|
| Change In Inventory |
|
-0.08
-94.67%
|
-0.04
-23.60%
|
-0.04
-154.30%
|
0.06
|
| Change In Payables And Accrued Expense |
|
0.19
-54.96%
|
0.42
+241.90%
|
-0.29
+71.46%
|
-1.03
|
| Change In Payable |
|
0.19
-54.96%
|
0.42
+241.90%
|
-0.29
+71.46%
|
-1.03
|
| Change In Account Payable |
|
0.19
-59.27%
|
0.46
+283.65%
|
-0.25
+77.20%
|
-1.10
|
| Change In Other Working Capital |
|
-0.10
-236.98%
|
0.07
+408.71%
|
-0.02
+99.22%
|
-3.04
|
| Change In Other Current Assets |
|
-0.01
+50.41%
|
-0.03
-123.69%
|
0.12
+24.72%
|
0.09
|
| Change In Other Current Liabilities |
|
—
|
0.00
+100.00%
|
-0.00
|
—
|
| Investing Cash Flow |
|
-0.62
-1236.23%
|
-0.05
+90.58%
|
-0.49
-15.98%
|
-0.42
|
| Cash Flow From Continuing Investing Activities |
|
-0.62
-1236.23%
|
-0.05
+90.58%
|
-0.49
-15.98%
|
-0.42
|
| Net PPE Purchase And Sale |
|
-0.62
-1236.23%
|
-0.05
+90.58%
|
-0.49
-15.98%
|
-0.42
|
| Purchase Of PPE |
|
-0.62
-1236.23%
|
-0.05
+90.58%
|
-0.49
-15.98%
|
-0.42
|
| Capital Expenditure |
|
-0.62
-1236.23%
|
-0.05
+90.58%
|
-0.49
-15.98%
|
-0.42
|
| Financing Cash Flow |
|
5.20
+246.30%
|
-3.55
+52.92%
|
-7.54
-65.18%
|
-4.57
|
| Cash Flow From Continuing Financing Activities |
|
5.20
+246.30%
|
-3.55
+52.92%
|
-7.54
-65.18%
|
-4.57
|
| Net Issuance Payments Of Debt |
|
0.02
+116.11%
|
-0.12
+0.52%
|
-0.12
+32.71%
|
-0.17
|
| Net Long Term Debt Issuance |
|
0.02
+116.11%
|
-0.12
|
—
|
—
|
| Net Short Term Debt Issuance |
|
—
|
-0.12
+0.52%
|
-0.12
+32.71%
|
-0.17
|
| Net Common Stock Issuance |
|
5.04
|
0.00
|
—
|
—
|
| Cash Dividends Paid |
|
0.00
+100.00%
|
-3.33
+55.00%
|
-7.40
-66.40%
|
-4.45
|
| Net Other Financing Charges |
|
0.14
+226.27%
|
-0.11
-255.09%
|
-0.03
-158.99%
|
0.05
|
| Changes In Cash |
|
0.03
+101.07%
|
-3.06
-194.55%
|
-1.04
-123.73%
|
4.37
|
| Beginning Cash Position |
|
2.10
-59.31%
|
5.16
-16.76%
|
6.19
+240.42%
|
1.82
|
| End Cash Position |
|
2.13
+1.56%
|
2.10
-59.31%
|
5.16
-16.76%
|
6.19
|
| Free Cash Flow |
|
-5.16
-1144.87%
|
0.49
-92.40%
|
6.51
-27.24%
|
8.94
|
| Interest Paid Supplemental Data |
|
0.00
-50.20%
|
0.01
-33.93%
|
0.01
+32.90%
|
0.01
|
| Change In Income Tax Payable |
|
0.00
+100.19%
|
-0.04
-2.33%
|
-0.04
-160.56%
|
0.07
|
| Change In Tax Payable |
|
0.00
+100.19%
|
-0.04
-2.33%
|
-0.04
-160.56%
|
0.07
|
| Common Stock Issuance |
|
5.04
|
0.00
|
—
|
—
|
| Issuance Of Capital Stock |
|
5.04
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-31 View
- 8-K2026-03-31 View
- 42026-03-26 View
- 8-K2026-03-12 View
- 42026-03-10 View
- 8-K2026-01-27 View
- 42026-01-06 View
- 8-K2025-12-31 View
- 42025-12-18 View
- 42025-12-15 View
- 42025-12-12 View
- 42025-12-10 View
- 8-K2025-12-08 View
- 8-K2025-12-05 View
- 10-Q2025-11-14 View
- 8-K2025-11-14 View
- 10-Q2025-08-14 View
- 8-K2025-08-14 View
- 8-K2025-07-25 View
- 10-Q2025-05-15 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|